title: [Adverse reactions to anti-hormonal therapy affects adherence].
authors.affiliation: Södersjukhuset - Stockholm, Sweden - onkologkliniken Stockholm, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: von Wachenfeldt
authors.forename: Anne
authors.initials: A
authors.lastname: Andersson
authors.forename: Tommy
authors.initials: T
authors.lastname: Fornander
authors.forename: Erika
authors.initials: E
authors.lastname: Isaksson Friman
authors.forename: Aina
authors.initials: A
authors.lastname: Johnsson
authors.forename: Eleonor
authors.initials: E
authors.lastname: Uddbom
authors.forename: Anna-Carin
authors.initials: AC
authors.lastname: Uttermalm
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D055118:Medication Adherence; D009376:Neoplasms, Hormone-Dependent / Q000517:prevention & control; D011788:Quality of Life; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004967:Estrogens; D013629:Tamoxifen